These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 27744331)

  • 1. Cellular strategies to cope with protein aggregation.
    Scior A; Juenemann K; Kirstein J
    Essays Biochem; 2016 Oct; 60(2):153-161. PubMed ID: 27744331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PolyQ-expanded proteins impair cellular proteostasis of ataxin-3 through sequestering the co-chaperone HSJ1 into aggregates.
    Yue HW; Hong JY; Zhang SX; Jiang LL; Hu HY
    Sci Rep; 2021 Apr; 11(1):7815. PubMed ID: 33837238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
    Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
    Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein Misfolding Diseases.
    Hartl FU
    Annu Rev Biochem; 2017 Jun; 86():21-26. PubMed ID: 28441058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Nucleolus as a Proteostasis Regulator.
    Amer-Sarsour F; Ashkenazi A
    Trends Cell Biol; 2019 Nov; 29(11):849-851. PubMed ID: 31473054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms and Functions of Spatial Protein Quality Control.
    Sontag EM; Samant RS; Frydman J
    Annu Rev Biochem; 2017 Jun; 86():97-122. PubMed ID: 28489421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shape matters: the complex relationship between aggregation and toxicity in protein-misfolding diseases.
    Ries HM; Nussbaum-Krammer C
    Essays Biochem; 2016 Oct; 60(2):181-190. PubMed ID: 27744334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein aggregation in cell biology: An aggregomics perspective of health and disease.
    Cox D; Raeburn C; Sui X; Hatters DM
    Semin Cell Dev Biol; 2020 Mar; 99():40-54. PubMed ID: 29753879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chaperone AMPylation modulates aggregation and toxicity of neurodegenerative disease-associated polypeptides.
    Truttmann MC; Pincus D; Ploegh HL
    Proc Natl Acad Sci U S A; 2018 May; 115(22):E5008-E5017. PubMed ID: 29760078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clearance of misfolded and aggregated proteins by aggrephagy and implications for aggregation diseases.
    Hyttinen JM; Amadio M; Viiri J; Pascale A; Salminen A; Kaarniranta K
    Ageing Res Rev; 2014 Nov; 18():16-28. PubMed ID: 25062811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade.
    Chiti F; Dobson CM
    Annu Rev Biochem; 2017 Jun; 86():27-68. PubMed ID: 28498720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Misfolding and aggregation in neurodegenerative diseases: protein quality control machinery as potential therapeutic clearance pathways.
    Koszła O; Sołek P
    Cell Commun Signal; 2024 Aug; 22(1):421. PubMed ID: 39215343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of Amyloid States by Molecular Chaperones.
    Wentink A; Nussbaum-Krammer C; Bukau B
    Cold Spring Harb Perspect Biol; 2019 Jul; 11(7):. PubMed ID: 30755450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein Disaggregation in Multicellular Organisms.
    Nillegoda NB; Wentink AS; Bukau B
    Trends Biochem Sci; 2018 Apr; 43(4):285-300. PubMed ID: 29501325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining the limits: Protein aggregation and toxicity in vivo.
    Holmes WM; Klaips CL; Serio TR
    Crit Rev Biochem Mol Biol; 2014; 49(4):294-303. PubMed ID: 24766537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal aggregates: formation, clearance, and spreading.
    Lim J; Yue Z
    Dev Cell; 2015 Feb; 32(4):491-501. PubMed ID: 25710535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of protein homeostasis in health, aging and disease.
    Goloubinoff P
    Swiss Med Wkly; 2016; 146():w14306. PubMed ID: 27045704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein folding, misfolding and quality control: the role of molecular chaperones.
    Papsdorf K; Richter K
    Essays Biochem; 2014; 56():53-68. PubMed ID: 25131586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular chaperones antagonize proteotoxicity by differentially modulating protein aggregation pathways.
    Douglas PM; Summers DW; Cyr DM
    Prion; 2009; 3(2):51-8. PubMed ID: 19421006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo aspects of protein folding and quality control.
    Balchin D; Hayer-Hartl M; Hartl FU
    Science; 2016 Jul; 353(6294):aac4354. PubMed ID: 27365453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.